Genetic Engineering & Biotechnology News features Taconic Biosciences because of their knowledge of Immuno-Oncology research:
"Predictive Models Can Reduce Late-Stage Failures and Accelerate Time-to-Market for Effective Drug Candidates - Our ability to understand the complexity of human cancer progression was once limited by research models that did not recapitulate the disease with full accuracy. Those limitations are now behind us. Thanks to advances in immune-deficient and genetically engineered mouse models (GEMs), researchers are able to apply better tools."
"Predictive Models Can Reduce Late-Stage Failures and Accelerate Time-to-Market for Effective Drug Candidates - Our ability to understand the complexity of human cancer progression was once limited by research models that did not recapitulate the disease with full accuracy. Those limitations are now behind us. Thanks to advances in immune-deficient and genetically engineered mouse models (GEMs), researchers are able to apply better tools."
Read the complete article at: Genengnews.com